Pharma ETFs in Focus Post Q4 Earnings
February 05, 2021 at 14:48 PM EST
The slew of Q4 results has led to mixed trading in pharma ETFs over the past 10 days. Here is a highlight of those in detail.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.